Beyond Stage IV: Rethinking Oligometastatic Lung Cancer
In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the evolving management of oligometastatic lung cancer. They break down key definitions, discuss whe...
1 Syys 47min
LCC in Korean: The Role of Immunotherapy in Lung Cancer
In this Korean-language episode of Lung Cancer Considered, Dr. Chul Kim is joined by Dr. Hye-Ryun Kim and Dr. Young Kwang Chae to discuss the evolving role of immunotherapy across the lung cancer trea...
28 Elo 46min
The Global Fight Against Lung Cancer: A Conversation with WHO's José Luis Castro
Host Dr. Stephen Liu is joined by José Luis Castro, WHO Director-General Special Envoy for Chronic Respiratory Diseases, for a thought-provoking discussion on why lung cancer must be recognized as a g...
25 Elo 29min
LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology
In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Mark Lewis and Dr. Michael Maddaus for a candid conversation about physician wellness, burnout, grief, and resilienc...
18 Elo 47min
LCC Advances in ALK+ Cancer in Cantonese
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Tony Mok, Dr. Chao Zhang, and Dr. Wen-Zhao Zhong. The...
14 Elo 46min
Treating Advanced Thymic Cancers
Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and multidisciplinary management. In this episode of Lung Cancer Considered, Dr. Stephen Liu is joined...
4 Elo 59min
FDA Approval: Zidesamtinib and ROS1 NSCLC
Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib for those previously treated with a ROS1 tyrosine kinase inhibitor. In this episode, Dr. Stephe...
28 Heinä 24min
